But lower gross margin caused -8% adj. EBITA vs ABGe Demand is good but supply chain is challenging ...
Redeye sees a mixed Q1 report from Proact, with solid organic growth in both Cloud and Support being...
Utvecklingen går framåt och vi på Analysguiden räknar med att samtliga av Biotechs tre projekt under...
CapMan reports its Q1 results on April 28th. We expect rather good results but have lowered our prof...
Q1 earnings will be affected by destocking and high costs.
We take a more cautious view ahead of Atria's Q1 results due on 3 May.
Stockholm-oriented names highlight pick-up in the city Tougher but so far manageable funding conditi...
Q1 report due on Wednesday, 18 May Environmental permit application was submitted in Q1 Company expe...
Idag tillkännagav GPX Medical att den kliniska forskaren och neonatologen Jurate Panaviene presenter...
Q1 report due on Wednesday 27 April Strong series production, softer equipment sales 21x ’22e EV/EBI...
Redeye is encouraged by Isofol starting analysis of AGENT data, with top-line data some two to four ...
The Thoracic recovery continues, and together with well-balanced and high organic growth, we expect ...
We have lowered our 2022e sales by 9% following a weaker short-term outlook for wind power.
Scanfil’s profitability is set to improve over the course of the year despite the still tight compon...
Under första kvartalet var Svedbergs organiska tillväxt goda 13 procent.
Taaleri is selling its stake in Ficolo and exiting Taaleri Datacenter, through which Taaleri and its...
Nitro Games delivered a solid report. Revenue was 24% ahead of our expectations, while profitability...
Redeye notes that PiezoMotor continues to show impressive growth in the first quarter, proforma 24% ...
Ahead of Rovio's Q1 report, we adjust our estimates mainly for FX tailwinds from the stronger USD.
CapMan will report its Q1 results on 28 April. We take a more cautious view on fair value changes an...
